BCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024
BOSTON, April 2, 2024 /PRNewswire/ -- According to the latest BCC Research study, the demand for Top Ten Suppliers of Synthetic Biology Technology is estimated to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.
- With growing interest and investment from countries worldwide, synthetic biology promises sustainable solutions and transformative applications across industries.
- Furthermore, it provides forecasts for 2028, allowing stakeholders to anticipate future trends and opportunities in the synthetic biology sector.
- Growth in Synthetic Biology Foundries: Synthetic biology foundries serve as collaborative hubs for research and development, providing access to shared resources, expertise, and standardized biological parts.
- Increasing Research and Development Investment by Pharma Companies: Pharmaceutical companies are increasingly recognizing the potential of synthetic biology and investing in research and development efforts.